Reliable Drainage
Without Exception

CirculaTech is developing proprietary medical technology
intended to improve the reliability of postoperative drainage
in cardiothoracic care.

CLINICAL NEED

Retained Blood

in the chest, following cardiothoracic surgery is attributed to incomplete drainage caused by clogged surgical drains. This undrained blood leads to increased morbidity, mortality, and length of stay of patients.1,3

CirculaTech is addressing this need by developing a self-irrigating surgical drain designed to proactively maintain patency and improve the reliability of postoperative drainage.

19%

Patients are affected by retained blood3

$10k

Average increased cost per patient2

Increased ICU hours3,5, length of stay3,4, & complications3,4,5

5×

Increase in mortality3

References
  1. Karimov JH, Gillinov AM, Schenck L, et al. Incidence of chest tube clogging after cardiac surgery: a single-centre prospective observational study. Eur J Cardiothorac Surg. 2013;44(6):1029–1036.
  2. Thomas N. Retained Blood Syndrome and 90-day care costs. Dexur.
  3. Balzer F, von Heymann C, Boyle EM, et al. Impact of retained blood requiring reintervention on outcomes after cardiac surgery. J Thorac Cardiovasc Surg. 2016;152(2):595–601.e4.
  4. Tauriainen T, Kinnunen EM, Koski-Vähälä J, et al. Outcome after procedures for retained blood syndrome in coronary surgery. Eur J Cardiothorac Surg. 2017;51(6):1078–1085.
  5. Gerdisch MW, Johns C, Parikshak M, Barksdale A, Perrault LP. Active Chest Tube Clearance Added to an Enhanced Recovery After Cardiac Surgery (ERAS) Program Improves Outcomes and Reduces Resource Utilization. Innovations (Phila). 2025;20(2):194–200.
VALIDATION

Supported by Leading Institutions

We are proud to collaborate with world-class organizations across healthcare,
research, and innovation.

TEAM

Founding Team & Advisory Board

Founder & CEO

Jake Pistiner

Jake Pistiner

Founder & CEO

M.S. Biomedical Engineering
Georgia Tech

Clinical & Technical Advisory

Glenn Egrie

Glenn Egrie MD

Clinical

Cardiothoracic Surgeon,
Sutter Health

Chris Ross

Chris Ross

R&D

President,
Engineering Resources Group

Jack Griffis

Jack Griffis

Manufacturing

CTO, Kessel Medical

Commercial & Strategic Advisory

Maxim Budyansky

Maxim Budyansky

Full Product Lifecycle /
Sales / Commercialization

Exited Founder & Investor

Ward Broom

Ward Broom

Bis Dev &
Commercialization

Exited Founder & Investor